SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001849521-22-000003
Filing Date
2022-04-04
Accepted
2022-04-04 18:57:49
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3659
  Complete submission text file 0001849521-22-000003.txt   5419
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 12117 BEE CAVES RD BLDG 3 STE 100 AUSTIN TX 78738
Business Address 203-969-5688
Sandford Nicole (Reporting) CIK: 0001849521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 22804569